Implant Surfaces

Executive Summary

Implant Surfaces is a privately-held medical device company headquartered in San Diego, California, specializing in advanced nanoscale surface engineering for implantable devices. The company's proprietary coatings are designed to enhance biocompatibility, promote specific cell attachment, and provide controlled antimicrobial properties, addressing critical challenges in implant integration and infection prevention. By integrating physics, microbiology, and protein chemistry, Implant Surfaces develops solutions for difficult interface problems between medical devices and the human body. Founded in 2010, the company remains private and has not disclosed financial details or stage. Despite limited public information, its focus on surface modification—a key differentiator in the implant market—positions it for potential partnerships or licensing deals with larger orthopedic or dental implant manufacturers.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for antimicrobial coating on orthopedic implants60% success
• Q2 2026Strategic partnership or licensing agreement with a major implant manufacturer50% success
• Q3 2026Publication of preclinical data demonstrating improved osseointegration70% success